Wide-moat McCormick (MKC) ended the year on a solid note, posting 2.4% underlying fourth-quarter sales growth and 50 basis points of adjusted operating margin improvement to 18.4%. The top-line gain is notable because it came on top of a 5% bump last year and reflected broad-based growth across the consumer (up 2.4%) and industrial (up 2.1%) segments. We think this performance resulted from McCormick’s leading brands, solid retail relationships, and cost edge, which in combination support our wide moat rating. But McCormick isn’t resting on its laurels; it intends to drive further efficiency savings (with plans to shed more than $400 million in costs over the next few years) as a means by which to fuel brand spending, which should ensure the company maintains a leading competitive edge.
For fiscal 2017, management anticipates mid- to high-single-digit organic sales growth and adjusted earnings per share of $4.05-$4.13, a touch below our $4.23 expectation partly due to a slightly higher tax rate assumption. Even after incorporating a more modest near-term earnings outlook, we don’t foresee a material change to our $91 fair value estimate, outside of a $1-$3 increase to account for additional cash generated since our last update. Our long-term outlook, which calls for 4% sales growth--with just more than half of top-line growth each year resulting from higher volume and favorable mix and the remainder reflecting increased prices--and operating margins to approach 17.5% by the end of our 10-year explicit forecast (about 300 basis points above the average margin over the past five years), remains in place. However, with the shares trading at a premium to our valuation, we'd suggest investors await a more attractive entry point.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Erin Lash does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.